Stifel Financial
RNLX

Stifel Financial’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Stifel Financial’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-489,431
Closed -$102K – 3517
2024
Q3 		$102K Sell
489,431
-71,569
-13% -$22.9K ﹤0.01% 3237
2024
Q2 		$130K Buy
561,000
+2,600
+0.5% +$1.55K ﹤0.01% 3175
2024
Q1 		$480K Buy
+558,400
New +$382K ﹤0.01% 2636

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Stifel Financial's RNLX Position: Q4 2024 in Review

Stifel Financial sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 489,431 shares — an estimated $102K sold.

Stifel Financial first reported a position in RNLX in Q1 2024 and held it in 3 quarters. The position peaked at $480K in Q1 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Stifel Financial reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Stifel Financial sold 489,431 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $102K.
  • Stifel Financial first reported a position in Renalytix plc American Depositary Shares in Q1 2024 and held it in 3 quarters.
  • Stifel Financial's Renalytix plc American Depositary Shares position peaked at $480K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Stifel Financial's 13F filing for Q4 2024, filed 13 Feb 2025.